Your browser doesn't support javascript.
loading
Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS- S and MERS-S pseudotyped particles
Catherine Z. Chen; Miao Xu; Manisha Pradhan; Kirill Gorshkov; Jennifer Petersen; Marco R. Straus; Wei Zhu; Paul Shinn; Hui Guo; Min Shen; Carleen Klumpp-Thomas; Samuel G. Michael; Joshua Zimmerberg; Wei Zheng; Gary R Whittaker.
Afiliação
  • Catherine Z. Chen; National Center for Advancing Translational Sciences, NIH
  • Miao Xu; National Center for Advancing Translational Sciences, NIH
  • Manisha Pradhan; National Center for Advancing Translational Sciences, NIH
  • Kirill Gorshkov; National Center for Advancing Translational Sciences, NIH
  • Jennifer Petersen; Eunice Kennedy -Shriver National Institute of Child Health and Human Development, NIH
  • Marco R. Straus; Cornell University
  • Wei Zhu; National Center for Advancing Translational Sciences, NIH
  • Paul Shinn; National Center for Advancing Translational Sciences, NIH
  • Hui Guo; National Center for Advancing Translational Sciences, NIH
  • Min Shen; National Center for Advancing Translational Sciences, NIH
  • Carleen Klumpp-Thomas; National Center for Advancing Translational Sciences, NIH
  • Samuel G. Michael; National Center for Advancing Translational Sciences, NIH
  • Joshua Zimmerberg; Eunice Kennedy -Shriver National Institute of Child Health and Human Development, NIH
  • Wei Zheng; National Center for Advancing Translational Sciences, NIH
  • Gary R Whittaker; Cornell University
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-197988
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
While vaccine development will hopefully quell the global pandemic of COVID-19 caused by SARS-CoV-2, small molecule drugs that can effectively control SARS-CoV-2 infection are urgently needed. Here, inhibitors of spike (S) mediated cell entry were identified in a high throughput screen of an approved drugs library with SARS-S and MERS-S pseudotyped particle entry assays. We discovered six compounds (cepharanthine, abemaciclib, osimertinib, trimipramine, colforsin, and ingenol) to be broad spectrum inhibitors for spike-mediated entry. This work should contribute to the development of effective treatments against the initial stage of viral infection, thus reducing viral burden in COVID-19 patients. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=109 SRC="FIGDIR/small/197988v2_ufig1.gif" ALT="Figure 1"> View larger version (37K) org.highwire.dtl.DTLVardef@d60124org.highwire.dtl.DTLVardef@1e5152dorg.highwire.dtl.DTLVardef@d16655org.highwire.dtl.DTLVardef@1957bcc_HPS_FORMAT_FIGEXP M_FIG C_FIG
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...